Literature DB >> 19522801

Pregnancy outcome in women with factor V Leiden and recurrent miscarriage.

S Jivraj1, M Makris, S Saravelos, T C Li.   

Abstract

We compared the outcome of 25 untreated pregnancies among women with recurrent miscarriage (RM) at <12 weeks' gestation who were heterozygous for factor V Leiden with women with unexplained RM. The livebirth rate was lower among pregnancies in carriers of factor V Leiden (12/25; 48%) compared with pregnancies in women with unexplained RM (175/307; 57%), but the difference did not reach statistical significance. The best possible treatment regimen to improve livebirth rate in this group of women needs to be assessed in the form of a randomised controlled trial.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19522801     DOI: 10.1111/j.1471-0528.2009.02168.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  3 in total

1.  Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).

Authors:  B Toth; W Würfel; M K Bohlmann; G Gillessen-Kaesbach; F Nawroth; N Rogenhofer; C Tempfer; T Wischmann; M von Wolff
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-11       Impact factor: 2.915

2.  Prevalence and role of antithrombin III, protein C and protein S deficiencies and activated protein C resistance in Kosovo women with recurrent pregnancy loss during the first trimester of pregnancy.

Authors:  Ymer Mekaj; Shefqet Lulaj; Fetie Daci; Naser Rafuna; Ermira Miftari; Hakif Hoxha; Xhemile Sllamniku; Agon Mekaj
Journal:  J Hum Reprod Sci       Date:  2015 Oct-Dec

Review 3.  Factor V Leiden 1691G > A mutation and the risk of recurrent pregnancy loss (RPL): systematic review and meta-analysis.

Authors:  Mohammad Masoud Eslami; Majid Khalili; Mina Soufizomorrod; Saeid Abroun; Bahman Razi
Journal:  Thromb J       Date:  2020-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.